Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FOSAPREPITANT Cause Systemic lupus erythematosus? 131 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Systemic lupus erythematosus have been filed in association with FOSAPREPITANT. This represents 26.9% of all adverse event reports for FOSAPREPITANT.

131
Reports of Systemic lupus erythematosus with FOSAPREPITANT
26.9%
of all FOSAPREPITANT reports
68
Deaths
131
Hospitalizations

How Dangerous Is Systemic lupus erythematosus From FOSAPREPITANT?

Of the 131 reports, 68 (51.9%) resulted in death, 131 (100.0%) required hospitalization, and 69 (52.7%) were considered life-threatening.

Is Systemic lupus erythematosus Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT. However, 131 reports have been filed with the FAERS database.

What Other Side Effects Does FOSAPREPITANT Cause?

Dyspnoea (195) Infusion related reaction (167) Hypersensitivity (157) Duodenal ulcer perforation (155) Confusional state (149) Glossodynia (149) Folliculitis (146) Arthralgia (144) Blister (144) Discomfort (144)

What Other Drugs Cause Systemic lupus erythematosus?

ADALIMUMAB (11,880) METHOTREXATE (9,350) INFLIXIMAB (9,071) ABATACEPT (8,944) HYDROXYCHLOROQUINE (8,867) RITUXIMAB (8,819) PREDNISONE (8,799) LEFLUNOMIDE (8,669) TOCILIZUMAB (8,656) FOLIC ACID (8,360)

Which FOSAPREPITANT Alternatives Have Lower Systemic lupus erythematosus Risk?

FOSAPREPITANT vs FOSAPREPITANT DIMEGLUMINE FOSAPREPITANT vs FOSCARBIDOPA\FOSLEVODOPA FOSAPREPITANT vs FOSCARNET FOSAPREPITANT vs FOSFOMYCIN FOSAPREPITANT vs FOSFOMYCIN TROMETHAMINE

Related Pages

FOSAPREPITANT Full Profile All Systemic lupus erythematosus Reports All Drugs Causing Systemic lupus erythematosus FOSAPREPITANT Demographics